Earnings Feed
Start Free
Home/Filings/4/0000885590-10-000052
4//SEC Filing

Mayer Christine 4

Accession 0000885590-10-000052

CIK 0000885590other
View on SEC.govCompany Profile

Filed

Oct 5, 8:00 PM ET

Accepted

Oct 6, 3:00 PM ET

Size

12.7 KB

Accession

0000885590-10-000052

Insider Transaction Report

Form 4
Period: 2010-10-04
Valeant Pharmaceuticals International, Inc.VRX
Mayer Christine
SVP,BTA Pharmaceuticals, Inc.
Transactions
  • Award

    Restricted Share Units

    2010-10-04+27→ 7,641 total
    From: 2011-03-12Exp: 2011-03-12→ Common Stock, no par value (27 underlying)
  • Award

    Restricted Share Units

    2010-10-04+25→ 7,097 total
    From: 2013-02-17Exp: 2013-02-17→ Common Stock, no par value (25 underlying)
  • Award

    Restricted Share Units

    2010-10-04+24→ 6,687 total
    From: 2012-02-25Exp: 2012-02-25→ Common Stock, no par value (24 underlying)
  • Award

    Restricted Share Units

    2010-10-04+187→ 51,329 total
    From: 2014-08-05Exp: 2014-08-05→ Common Stock, no par value (187 underlying)
Footnotes (2)
  • [F1]Each Restricted Share Unit represents a contingent right to receive one share of Common Stock, no par value, of Valeant Pharmaceuticals International, Inc. (the "Common Stock").
  • [F2]Represents dividend equivalents accrued on Restricted Share Units as a result of a dividend paid on the Common Stock on October 4, 2010.

Documents

1 file

Issuer

Valeant Pharmaceuticals International, Inc.

CIK 0000885590

→
Entity typeother

Related Parties

1
  • filerCIK 0001477286

Filing Metadata

Form type
4
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 3:00 PM ET
Size
12.7 KB
View on SEC.gov